Summary
Elevance Health, Inc. (then operating as WellPoint, Inc.) filed this Form 8-K on January 13, 2014, to provide updated financial guidance ahead of its official fourth-quarter and full-year 2013 earnings release scheduled for January 29, 2014. The company anticipates its full-year 2013 net income per diluted share to be $8.20, with an adjusted net income per diluted share of $8.52. This adjusted figure excludes certain net costs totaling $0.32 per share, which include items like net realized gains on investments, impairment losses, debt extinguishment costs, and acquisition-related expenses. Furthermore, WellPoint indicated that its year-end 2013 medical enrollment surpassed 35.6 million members. The company also expects its full-year operating revenue, benefit expense ratio, and selling, general, and administrative expense ratio to fall within previously issued guidance ranges. This proactive disclosure aims to inform investors about the company's expected financial performance before the detailed earnings announcement, signaling confidence in meeting projections despite a series of specific adjustments.
Key Highlights
- 1WellPoint (now Elevance Health) provided an updated outlook for its full-year 2013 financial results.
- 2The company expects full-year 2013 net income per diluted share to be $8.20.
- 3Adjusted net income per diluted share for full-year 2013 is projected at $8.52, excluding $0.32 per share in net costs.
- 4Key adjustments to net income include realized investment gains/losses, impairment charges, debt extinguishment costs, and acquisition expenses.
- 5Year-end 2013 medical enrollment exceeded 35.6 million members.
- 6Full-year 2013 operating revenue, benefit expense ratio, and SG&A expense ratio are anticipated to be within prior guidance.
- 7Detailed 2013 financial results are scheduled for release on January 29, 2014.